Thymopentin stability in isolated human plasma
Lab research · 1979
- What was studied
- Isolated human plasma and a saline control.
- Main finding
- Apparent half-life in plasma · Approximately 30 seconds in isolated plasma. The investigators observed no comparable degradation in the saline control.
Reported findings and study design
Reported findings
Tritiated thymopentin was incubated in plasma and saline. Thin-layer chromatography and radiolabel measurements tracked the parent peptide and four tyrosine-containing breakdown products.
Population or model Isolated human plasma and a saline control.
Dose, route and schedule
Tritiated thymopentin was incubated in plasma and saline. Thin-layer chromatography and radiolabel measurements tracked the parent peptide and four tyrosine-containing breakdown products.
Protocol source ↗ · Original indexed abstract.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Apparent half-life in plasma | Approximately 30 seconds in isolated plasma. The investigators observed no comparable degradation in the saline control. |
This laboratory assay did not measure half-life after administration to people.
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- This laboratory assay did not measure half-life after administration to people.
Source details
Original indexed abstract.
Sources checked
Added to the library
Citation
J. P. Tischio, J. E. Patrick, H. S. Weintraub, M. Chasin, G. Goldstein. Thymopentin stability in isolated human plasma International Journal of Peptide and Protein Research 14(5), 479–484
Study source ↗ · DOI 10.1111/j.1399-3011.1979.tb01959.x · Bibliography entry · Link to this summary